Piramal Pharma Solutions

Piramal Pharma Solutions PPS is a CDMO offering end-to-end development and manufacturing solutions across the drug lifecycle.

We serve our clients through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including Drug Discovery Solutions, Process & Pharmaceutical Development services, Clinical Trial Supplies, Commercial supply of APIs, and Finished dosage forms. We also offer specialized services like the development and manufacture of Highly Potent APIs and Antibody Drug Conjugation. Our capability as an integrated service provider & experience with various technologies enables us to serve Innovator and Generic companies worldwide. For more information and updates, please visit: www.piramalpharmasolutions.com

Heading to Swiss Biotech Day in Basel this May?Connect with Hubert Lochard, Director – Business Development, who will be...
04/08/2026

Heading to Swiss Biotech Day in Basel this May?

Connect with Hubert Lochard, Director – Business Development, who will be on-site to discuss how Piramal Pharma Solutions supports biotech and pharma companies with integrated CDMO solutions across the drug development lifecycle.

From development through manufacturing, we work with partners to help advance complex programs with the speed, flexibility, and scientific expertise needed to move forward with confidence.

If you’re attending Swiss Biotech Day, let’s connect and explore how we can support your next milestone.

Basel, Switzerland
May 4–5, 2026

Rare diseases often come with limited treatment options due to small patient populations and complex development challen...
04/06/2026

Rare diseases often come with limited treatment options due to small patient populations and complex development challenges. New drug formulation plays a critical role in addressing these gaps by improving drug efficacy, safety, and delivery.

Advancements in technologies such as targeted drug delivery, biologics, and AI-driven development are enabling more precise and patient-centric therapies for rare conditions. These innovations are helping streamline R&D while improving therapeutic outcomes.

At Piramal Pharma Solutions, our expertise in pharmaceutical formulation development supports the creation of effective, scalable, and reliable treatments, helping partners bring therapies for rare diseases from concept to commercialization.

Click on the link below and head to our blog to learn more about new drug formulation for rare diseases: https://lnkd.in/dhHGNSqM

Sustainability in pharmaceutical development is no longer an afterthought — it is a critical design principle. Integrati...
04/03/2026

Sustainability in pharmaceutical development is no longer an afterthought — it is a critical design principle. Integrating green chemistry at the early stages of synthesis enables more efficient processes, reduced environmental impact, and smoother scale-up.

By making informed decisions around solvent selection, route optimization, and process design, organizations can balance speed, quality, and sustainability without compromise. Early-stage interventions not only minimize waste and cost but also improve overall manufacturability.

At Piramal Pharma Solutions, we embed green chemistry principles from discovery through development, helping design safer, scalable, and environmentally responsible processes for our partners.

Click on the link to explore how “greenness by design” is shaping the future of pharmaceutical synthesis in our whitepaper: https://business.piramalpharmasolutions.com/green_chemistry

Supporting Peptide Innovation from Development to Scale-Up: Inside Turbhe- Peptides R&D Capabilities.At our Peptides sit...
04/02/2026

Supporting Peptide Innovation from Development to Scale-Up: Inside Turbhe- Peptides R&D Capabilities.

At our Peptides site in Turbhe, India, R&D capabilities are built to support the complex and evolving needs of peptide development.

Our experienced team of experts support a range of capabilities including synthetic process development and optimization, process IP evaluation, development of non-infringing and cost-effective synthesis routes, impurity isolation and characterization, analytical method development and validation, and the manufacture of peptide fragments and intermediates.

Backed by dedicated infrastructure and technology transfer support for commercial scale-up, the site plays an important role in enabling peptide-based programs from early-stage development through scale-up readiness.

The site includes:
- Reaction capability from milligram to multigram scale
- 5 independent synthetic lines
- 3 downstream process lines with axial compression chromatography columns
- 2 dedicated freeze dryers for development
- Reverse osmosis facility

These capabilities support custom synthesis for peptide-based products, including early-stage and preclinical programs, as well as development of synthesis processes for future manufacturing scale-up.

CPhI Japan is where regional insight meets global capability and Piramal Pharma Solutions is ready to connect.Visit us a...
04/02/2026

CPhI Japan is where regional insight meets global capability and Piramal Pharma Solutions is ready to connect.

Visit us at CPhI Japan, Booth 1C-32, and meet Teppei Yamaguchi, Country Manager, Business Development, CDMO (Japan & Korea).

Teppei brings deep understanding of the Japan and Korea markets, helping bridge local innovation with our global integrated CDMO platform spanning APIs, drug products, and advanced therapies including ADCs.

If you’re looking for a partner who understands both regional dynamics and global ex*****on, let’s schedule time to meet at the booth.

It starts with complexity, moves through precision, and delivers what truly matters and that’s how progress is built, st...
04/01/2026

It starts with complexity, moves through precision, and delivers what truly matters and that’s how progress is built, step by step, detail by detail.

At Piramal Pharma Solutions, we engineer every stage with intent.

Visit our website to explore how we engineer progress across every stage: https://lnkd.in/gEEndBM5

As ADC pipelines become more competitive, payload-linker design is playing a more strategic role than ever before.The ri...
04/01/2026

As ADC pipelines become more competitive, payload-linker design is playing a more strategic role than ever before.

The right payload-linker approach can influence:
• Stability in circulation
• Release mechanism at target
• Overall therapeutic performance
• Manufacturability and scale-up readiness

In this Contract Pharma feature, we look at how payload-linker engineering can help differentiate ADC candidates and why access to the right development and manufacturing expertise is essential.

Read the full article here: https://www.contractpharma.com/library/payload-linker-engineering-as-a-differentiator-in-adc-development-and-manufacturing/?utm_campaign=CP%20Newsletter&utm_medium=email&_hsmi=411362863&utm_content=411362863&utm_source=hs_email

Japan, we’re ready!Piramal Pharma Solutions is excited to be at CPhI Japan- Booth 1C-32 connecting with partners across ...
03/31/2026

Japan, we’re ready!

Piramal Pharma Solutions is excited to be at CPhI Japan- Booth 1C-32 connecting with partners across the region and beyond.

Joining us will be Conor Barry, Vice President, Global Head of Bioconjugate and Large Molecule R&D, based at our Grangemouth site a key center of excellence for bioconjugation and large molecule R&D within Piramal Pharma Solutions.

From payload-linker strategy to integrated development and manufacturing, Conor will be available for mindful, science-led discussions on advancing your ADC program with confidence.

Stop by Booth 1C-32 and let’s connect global expertise with local opportunity.

03/30/2026

As Women’s Month comes to a close, we celebrate not just progress but the people driving it forward every day.

Here’s to the women who lead, innovate, support, discover, build, and inspire.

And here’s to continuing the momentum from this month and beyond.

From the boardroom to the bench, from strategy to science, women across Piramal Pharma continue to shape outcomes, teams, and possibilities.

As Women’s Month draws to a close, one thing is clear:
When women grow, businesses grow.
When women lead, teams thrive.
And when women are empowered, the future moves forward.

Why E&L studies matter:​• Extractables and leachables from packaging can impact patient safety and drug stability. For i...
03/30/2026

Why E&L studies matter:​
• Extractables and leachables from packaging can impact patient safety and drug stability. For injectables, inhalables, and sensitive dosage forms, regulators now expect comprehensive E&L qualification.​

​What we offer at PPDS, Ahmedabad​
• End-to-end E&L support for container-closure systems, rubber stoppers, and packaging materials—aligned with global guidelines.​

​Our Services:​

• Extractables profiling under worst-case conditions​

• Leachables testing in the actual drug matrix​

• Risk-based assessments per PQRI, USP /​

• TTC-based toxicological evaluation​

​Technologies:​
• GC-MS, LC-MS, ICP-MS, IC, FTIR, TOC, UV, NMR (as applicable)​

​Why partner with us?​
Our expert team ensures scientific rigor, compliant study designs, and regulatory-ready interpretations—helping you confidently qualify your packaging systems.

At Piramal Pharma Solutions, our focus is clear: improving patients’ lives drives everything we do. From shaping our str...
03/27/2026

At Piramal Pharma Solutions, our focus is clear: improving patients’ lives drives everything we do. From shaping our strategies to guiding collaborations with partners, we ensure that every solution we develop across the drug lifecycle serves patients first.

We bring this commitment to life through rigorous governance, initiatives that raise awareness at every site, and learning programs that embed a patient-focused mindset across our teams.

By combining these efforts, we turn patient centricity into action: anchored in responsibility, collaboration, and shared purpose.

Learn more about how we prioritize patients in every step of our work:
https://www.piramalpharmasolutions.com/why-partner-with-us/patient-centricity

Celebrating 20 years of pharmaceutical manufacturing excellence at Morpeth. Piramal Pharma Solutions is proud to commemo...
03/27/2026

Celebrating 20 years of pharmaceutical manufacturing excellence at Morpeth.

Piramal Pharma Solutions is proud to commemorate this milestone with the procurement of the Korsch X3 Tablet Press a state-of-the-art, custom-built addition designed to support the site’s evolving manufacturing needs.
Equipped with full Band 5 containment, the Korsch X3 enables the safe and contained manufacture of highly potent drug products at both clinical and commercial scales.

This investment further strengthens Morpeth’s ability to support the growing demand for complex therapies, while reinforcing our continued focus on innovation, safety, quality, and Patient Centricity.

As we celebrate two decades of achievement, we remain committed to building the capabilities needed to help bring important therapies to patients around the world.

Read the full press release: https://lnkd.in/dnsrH-ph


Address

18655 Krause Street
Riverview, MI
48193

Website

Alerts

Be the first to know and let us send you an email when Piramal Pharma Solutions posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category